InsidersTradesSigma
Track the Enovix Corp stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Chemicals & Materials sector, Enovix Corp has recorded 518 reports. Market capitalisation: €737.3m. The latest transaction was disclosed on 1 September 2026 (Attribution). Among the most active insiders: Truong Kristina. Every trade is accessible without an account.
518
Insider Decl.
n/a
Thresholds
€32m
17 ops.
Buy Volume
€10m
32 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Enovix Corp Buy (bullish), based on 10 analysts. Average price target: US$11.35.
40Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,171 of 29,062 companies
12.5
score / 100
Value11
Quality14
FCF yld-15%
Earn yld-21%
EV/EBITDA·
ROE-81%
Gross mgn19%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 September 2026
Declarations518 total
19,060 shares0Common StockSEC:0001564606-26-000013:0
10,093 shares@ US$3.36Common StockSEC:0001564606-26-000013:1
18,546 shares0Common StockSEC:0001975015-26-000049:0
9,821 shares@ US$3.36Common StockSEC:0001975015-26-000049:1
12,512 shares0Common StockSEC:0002052363-26-000052:0
6,626 shares@ US$3.36Common StockSEC:0002052363-26-000052:1
2,221 shares@ US$3.270.0010% mcap0.4% of flowCommon StockSEC:0001975015-26-000048:0
1,015 shares@ US$4.430.0007% mcap1.2% of flowCommon StockSEC:0002052363-26-000050:0
4,300 shares@ US$4.700.0030% mcap0.2% of flowCommon StockSEC:0001961877-26-000043:0
936 shares@ US$4.700.0006% mcap0.2% of flowCommon StockSEC:0001975015-26-000046:0
253 shares@ US$4.640.0002% mcap0.3% of flowCommon StockSEC:0002052363-26-000047:0
13,579 shares@ US$4.290.0086% mcap100.0% of flowCommon StockSEC:0002147247-26-000004:2
932,400 shares0Common StockSEC:0002147247-26-000004:0
23,310 shares0Common StockSEC:0002147247-26-000004:1
2,221 shares@ US$3.950.0010% mcap0.5% of flowCommon StockSEC:0001975015-26-000043:0
17,651 shares@ US$4.720.012% mcap0.7% of flowCommon StockSEC:0001961877-26-000041:0
19,824 shares@ US$5.060.015% mcap14.2% of flowCommon StockSEC:0001564606-26-000011:0
1,015 shares@ US$4.950.0007% mcap1.3% of flowCommon StockSEC:0002052363-26-000045:1
253 shares@ US$5.200.0002% mcap0.3% of flowCommon StockSEC:0002052363-26-000045:0
4,301 shares@ US$5.130.0033% mcap0.2% of flowCommon StockSEC:0001961877-26-000039:1
13,658 shares@ US$5.130.010% mcap0.6% of flowCommon StockSEC:0001961877-26-000039:0
1,680 shares@ US$5.130.0013% mcap2.3% of flowCommon StockSEC:0002052363-26-000043:0
936 shares@ US$5.130.0007% mcap0.3% of flowCommon StockSEC:0001975015-26-000041:0
3,359 shares@ US$5.130.0026% mcap1.0% of flowCommon StockSEC:0001975015-26-000041:1
3,336 shares@ US$5.850.0029% mcap1.6% of flowCommon StockSEC:0001975015-26-000039:0
25 of 518 declarations
关于 Enovix Corp
Enovix Corp. (Nasdaq: ENVX) 是一家美国下一代电池公司，专注于硅阳极锂离子电池和专有架构，旨在提供更高的能量密度而不影响安全性。公司总部位于美国加利福尼亚州弗里蒙特，由其联合创始人于2000年代中期创立，其明确使命是：显著改善移动设备、联网电子产品以及长期来看其他高能耗应用的电池性能。Enovix于2021年通过SPAC合并上市，目前在纳斯达克上市，使其成为一家具有增长导向的股票，并对技术采用周期和制造执行具有重要影响。 公司的核心业务是先进电池的设计、工业化和商业化。其平台围绕专有的硅阳极架构构建，Enovix常将其描述为3D电池结构，旨在在紧凑的设备外形尺寸内增加能量容量。Enovix的目标应用包括智能手机、可穿戴设备、移动计算、智能设备和新兴的AI赋能消费产品。公司还为智能眼镜和其他需要在小尺寸内实现高能量密度的设备销售电池产品。 从竞争角度来看，Enovix在一个由大型亚洲锂离子电池制造商和一小部分先进材料创新者主导的市场中运营。其定位是利基技术颠覆者，而非大众市场商品供应商。投资案例基于性能差异化、安全性和小型化，这可以支持高端OEM关系和设计中标。与此同时，这种模式也伴随着执行风险：扩大制造规模、将客户兴趣转化为批量出货以及保持财务纪律仍然至关重要。 根据公司最近的披露，Enovix的总部设在美国，同时在马来西亚和韩国运营制造和/或运营设施。最近的发展对股票故事至关重要：在2025年和2026年，Enovix强调了其AI-1智能手机电池平台的推出，开始商业化生产硅阳极智能眼镜电池，并预示了大规模生产的进展。它还增加了商业领导力以支持规模扩大和收入增长。对于法语投资者而言，Enovix应被视为一家具有差异化电池IP的高增长技术材料公司，但其高度依赖于商业化里程碑、产能提升执行和客户采纳。
